Filtering article containing titania nanotubes
US-10702833-B2 · Jul 7, 2020 · US
US11659847B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11659847-B2 |
| Application number | US-202218048471-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 21, 2022 |
| Priority date | Sep 9, 2019 |
| Publication date | May 30, 2023 |
| Grant date | May 30, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of removing one or more antibiotics from a dairy product, the method involve passing the dairy product comprising an antibiotic in a first amount through a bulk comprising, relative to a total bulk weight, at least 75 wt. % of titanium oxide nanostructures, to provide the dairy product comprising the antibiotic in a second, lesser amount, wherein the nanostructures have lengths at least two-fold in excess of their width and height. Bulk materials useful in this or related methods or applications may have loosely tangled, noodle-like morphologies on sub-100 nm scale, and need not employ graphene and/or polymeric support networks in columns, generally having only titanium oxides without silicon or iron oxides.
Opening claim text (preview).
The invention claimed is: 1. A dairy mixture for purification, comprising: titanium oxide nanotubes having a formula H x Na 2-x Ti 2 O 5 .(H 2 O), wherein x≤2; an antibiotic; and a dairy product, wherein the nanotubes have an average diameter in a range of from 5 to 200 nm. 2. The mixture of claim 1 , wherein the dairy product is milk and/or the antibiotic is a β-lactam antibiotic. 3. The mixture of claim 1 , wherein the first amount of the antibiotic is in a range of from 10 to 1200 ppm. 4. The mixture of claim 1 , wherein the average diameter of the titanium oxide nanotubes is no greater than 20 nm. 5. The mixture of claim 1 , wherein the titanium oxide nanotubes have a BET surface area in a range of from 175 to 225 m 2 /g, and/or an average pore size in a range of from 65 to 85 Å, and/or an average particle size in a range of from 60 to 125 μm. 6. The mixture of claim 1 , wherein the titanium oxide nanotubes have an anatase crystal structure.
Compounds of Ti, Zr, Hf · CPC title
using adsorption or absorption agents, resins, synthetic polymers, or ion exchangers · CPC title
Sorbent size or size distribution, e.g. particle size · CPC title
Oxides or hydroxides · CPC title
with size in the range 1-100 nanometers, e.g. nanosized particles, nanofibers, nanotubes, nanowires or the like (carbon nanostructures B01J20/205) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.